Tandem Historical Income Statement
| TNDM Stock | USD 44.72 8.16 22.32% |
Historical analysis of Tandem Diabetes income statement accounts such as Research Development of 178.2 M, Total Operating Expenses of 548.3 M, Income Tax Expense of 2.5 M or Total Revenue of 785.1 M can show how well Tandem Diabetes Care performed in making a profits. Evaluating Tandem Diabetes income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tandem Diabetes's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tandem Diabetes Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tandem Diabetes Care is a good buy for the upcoming year.
Tandem |
About Tandem Income Statement Analysis
Tandem Diabetes Care Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tandem Diabetes shareholders. The income statement also shows Tandem investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tandem Diabetes Income Statement Chart
Tandem Diabetes Care Income Statement is one of the three primary financial statements used for reporting Tandem's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Tandem Diabetes Care revenue and expense. Tandem Diabetes Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Tandem Diabetes' Gross Profit is very stable compared to the past year. As of the 4th of May 2024, Cost Of Revenue is likely to grow to about 399 M, while Interest Expense is likely to drop about 5.8 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tandem Diabetes Care. It is also known as Tandem Diabetes overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Tandem Diabetes Care operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Tandem Diabetes Care is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Tandem Diabetes income statement and is an important metric when analyzing Tandem Diabetes Care profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Tandem Diabetes Care financial statement analysis. It represents the amount of money remaining after all of Tandem Diabetes Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Tandem Diabetes' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tandem Diabetes Care current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At this time, Tandem Diabetes' Gross Profit is very stable compared to the past year. As of the 4th of May 2024, Cost Of Revenue is likely to grow to about 399 M, while Interest Expense is likely to drop about 5.8 M.
| 2021 | 2023 | 2024 (projected) | Interest Expense | 4.3M | 7.6M | 5.8M | Depreciation And Amortization | 13.8M | 15.7M | 9.4M |
Tandem Diabetes income statement Correlations
Click cells to compare fundamentals
Tandem Diabetes Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tandem Diabetes income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 6.1M | 10.5M | 13.8M | 31.0M | 15.7M | 9.4M | |
| Interest Expense | 7.6M | 78K | 12.2M | 4.3M | 7.6M | 5.8M | |
| Selling General Administrative | 165.7M | 204.9M | 261.5M | 335.7M | 352.5M | 370.1M | |
| Other Operating Expenses | 379.0M | 506.8M | 680.1M | 863.0M | 902.2M | 947.3M | |
| Operating Income | (16.7M) | (8.0M) | 8.8M | (61.8M) | (233.2M) | (221.6M) | |
| Ebit | (16.7M) | (8.0M) | 8.8M | (61.8M) | (133.9M) | (127.2M) | |
| Research Development | 45.2M | 63.6M | 92.1M | 139.1M | 169.7M | 178.2M | |
| Ebitda | (10.7M) | 2.5M | 22.7M | (30.8M) | (118.2M) | (112.3M) | |
| Total Operating Expenses | 210.9M | 268.5M | 353.6M | 474.8M | 522.2M | 548.3M | |
| Income Before Tax | (24.6M) | (36.3M) | 15.9M | (92.9M) | (220.3M) | (209.2M) | |
| Total Other Income Expense Net | (7.9M) | (28.3M) | 7.1M | (31.0M) | (78.8M) | (74.8M) | |
| Net Income | (24.8M) | (34.4M) | 15.6M | (94.6M) | (222.6M) | (211.5M) | |
| Income Tax Expense | 149K | (1.9M) | 335K | 1.7M | 2.4M | 2.5M | |
| Total Revenue | 362.3M | 498.8M | 702.8M | 801.2M | 747.7M | 785.1M | |
| Gross Profit | 194.2M | 260.5M | 376.2M | 413.0M | 367.7M | 386.1M | |
| Cost Of Revenue | 168.1M | 238.3M | 326.6M | 388.2M | 380.0M | 399.0M | |
| Net Income From Continuing Ops | (24.8M) | (34.4M) | 15.6M | (94.6M) | (222.6M) | (211.5M) | |
| Non Operating Income Net Other | (7.9M) | (28.3M) | (6.8M) | (4K) | (3.6K) | (3.8K) | |
| Net Income Applicable To Common Shares | (24.8M) | (34.4M) | 15.6M | (94.6M) | (108.8M) | (114.2M) | |
| Tax Provision | 149K | (1.9M) | 335K | 1.7M | 2.4M | 2.5M | |
| Interest Income | 3.3M | 1.6M | 674K | 6.1M | 22.9M | 24.0M | |
| Net Interest Income | 3.2M | (11.2M) | (5.4M) | (152K) | 13.0M | 13.6M | |
| Reconciled Depreciation | 6.1M | 10.5M | 13.8M | 14.3M | 15.7M | 11.5M |
Tandem Diabetes Investors Sentiment
The influence of Tandem Diabetes' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tandem. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tandem Diabetes' public news can be used to forecast risks associated with an investment in Tandem. The trend in average sentiment can be used to explain how an investor holding Tandem can time the market purely based on public headlines and social activities around Tandem Diabetes Care. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tandem Diabetes' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tandem Diabetes' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tandem Diabetes' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tandem Diabetes.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tandem Diabetes in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tandem Diabetes' short interest history, or implied volatility extrapolated from Tandem Diabetes options trading.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Tandem Diabetes Care information on this page should be used as a complementary analysis to other Tandem Diabetes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Tandem Stock analysis
When running Tandem Diabetes' price analysis, check to measure Tandem Diabetes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tandem Diabetes is operating at the current time. Most of Tandem Diabetes' value examination focuses on studying past and present price action to predict the probability of Tandem Diabetes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tandem Diabetes' price. Additionally, you may evaluate how the addition of Tandem Diabetes to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Tandem Diabetes' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share (3.43) | Revenue Per Share 11.509 | Quarterly Revenue Growth (0.11) | Return On Assets (0.1) |
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.